Grade 4 immature teratoma followed by portal vein embolization and hepatectomy with recurrence: A case report

Author:

A Mousa Ahmed1,Khaled Agabawi Abdullah2,S Rozzah Rayan2,K Abdulwasie Hassan3

Affiliation:

1. Associate professor, Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah, Al Edara Street, Po. Box: 802000, Saudi Arabia

2. Teaching assistant, Department of Obstetrics and Gynecology, King Abdulaziz University, Jeddah, Al Edara Street, Po. Box: 802000, Saudi Arabia

3. Resident, Department of General Surgery, King Abdulaziz University, Jeddah, Al Edara Street, Po. Box: 802000, Saudi Arabia

Abstract

Introduction: Immature teratomas or in another way malignant germ cell tumors are considered a very rare type of aggressive ovarian cancers. Of teratomas it represents 1%. In ovarian cancers it still presents 1% and as an overall it presents 35.6% of all malignant ovarian germ cell tumors. In most cases it has been found during the first two decades of life. Case Report: The present case describes a case of a patient who was diagnosed with immature teratoma that was treated surgically and discovered sooner to have a liver metastasis that was treated with hepatic embolization and hepatectomy. Furthermore, she developed recurrence with lung metastasis that was intended to be treated with chemotherapy. Conclusion: Prognosis of this type of cancer is reported to be good as long as it is discovered and treated early in the course. Patients usually present before metastasis. In terms of liver metastasis our patient had a hepatic embolization followed by a right hepatectomy which when compared to other reported cases almost all had a hepatectomy without embolization. Five months later our patient presented with lung metastasis which is uncommon specially after the patient had a right hepatectomy. Based on these findings our patient had a very short disease-free period which is not typical for this kind of disease. Platinum-based chemotherapy is considered the standard of care as an adjuvant therapy. This patient showed resistance to cisplatin where up to our knowledge there were no reported cases that had resistance to this regimen.

Publisher

Edorium Journals Pvt. Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3